Skip to main content
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
// //

Alex Ruus

Tibor Kolley/The Globe and Mail

Alex Ruus is portfolio manager at Arrow Capital Management. His focus is North American equities.

Top Picks:

Gilead Sciences Inc. (GILD-Nasdaq)

Story continues below advertisement

Gilead is the world leader in developing and selling AIDS and Hepatitis medicines. The company is growing swiftly on the back of the launch of 2 new "best in class" Hepatitis medicines that are going to be the most successful drug launches in history. Gilead trades at an inexpensive 10 times earnings.

Neptune Technologies & Bioressources (NTB-TSX)

Neptune is an emerging neutraceutical/pharmaceutical company producing Neptune Krill Oil (NKO), a proprietary omega-3 phospholipid. The company is substantially undervalued and the stock is poised to outperform as its new manufacturing plant has recently comes into production and it's potentially revolutionary new drug, CaPre, approaches launch of crucial Phase 3 clinical trials.

Magna International (MG-TSX)

The world's fourth-largest auto maker, Magna continues to grow as it takes advantage of the globalization of the automobile business. It continues to grow profitably and trades at an inexpensive 10 times earnings and pays a growing dividend.

Past Picks: December 6, 2013

Alaris Royalty (AD-TSX)

Story continues below advertisement

Then: $34.25; Now: $33.49 -2.22%; Total return: +2.73%

Magna International (MG-TSX)

Then: $85.81; Now: $122.16 +42.36%; Total return: +44.45%

LyondellBasell Industries (LYB-NYSE)

Then: $76.55; Now: $74.62 -2.52%; Total return: +0.28%

Total return average: +15.82%

Story continues below advertisement

Market outlook:

The global economy continues its slow, steady recovery from the "Great Recession" of 2008-09. A recent pullback in the price of oil will put more money in consumers' pockets, helping to stimulate growth. This provides a perfect economic backdrop for leading companies with sustainable competitive advantage to thrive and grow shareholder value. Current equity markets are modestly undervalued with large divergences in valuations between companies providing excellent opportunities for disciplined investment funds like Exemplar Leaders and Northern Rivers Conservative Growth LP to continue to build client wealth.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies